Drug Profile
Research programme: antiviral therapeutics - Chimerix
Alternative Names: CMX 014; CMX 16669; CMX669Latest Information Update: 10 Mar 2023
Price :
$50
*
At a glance
- Originator Chimerix
- Class Drug conjugates; Hypoxanthines
- Mechanism of Action DNA-directed DNA polymerase inhibitors; Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cytomegalovirus infections; Hepatitis B; Hepatitis C; Influenza virus infections; Viral infections
Most Recent Events
- 10 Mar 2023 Discontinued - Preclinical for Cytomegalovirus infections in USA (PO) (Chimerix pipeline, February 2023)
- 10 Mar 2023 Discontinued - Preclinical for Viral infections in USA (PO) (Chimerix pipeline, February 2023)
- 10 Mar 2023 Discontinued for Influenza virus infections in USA (unspecified route) (Chimerix pipeline, February 2023)